ARDX
ARDX
NASDAQ · Biotechnology

Ardelyx Inc

$6.19
+0.01 (+0.16%)
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 16 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +661.6% upside
Low Target $33.22
Average Target $47.14
High Target $55.45
Current Price $6.19
Current
$6.19
Target
$47.14
$33.22 $47.14 avg $55.45
Scenario Analysis
Bear Case
$33.22
436.7%
Low target
Base Case
$47.14
+661.6%
Avg target
Bull Case
$55.45
+795.8%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$8.40
-26.3% from high
52-Week Low
$3.49
+77.4% from low
Target vs 52W High
$47.14
+461.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +5.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -46.4%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +191.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -9.5%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -36.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -45.5%